FDA Approval of New Alzheimer's Drug Offers Hope
In what many hope to be a new frontier for Alzheimer’s research and treatment, the FDA recently approved the use of aducanumab (brand name Aduhelm) for treatment of patients with Alzheimer’s disease. The drug, approved on June 7, 2021, is the first of its kind marketed to slow progression of the brain disease; other existing drugs only help manage the symptoms. The last time the FDA approved an Alzheimer’s drug was 2003. Aducanumab is intended to work by reducing the level of
